Achillion Pharmaceuticals

ACHN

3.40

-0.02

-0.6%

Stock Price
Open: 3.44
Prev. Close: 3.42
Low/Hi: 3.39 - 3.44
52-Week: 3.15 - 10.06
Volumes
Equity: 32,151
90-Day Avg: 1,456,703
Option:
90-Day Avg: 405
Volatility
Today: 18.8
20-Day: 56.1
52-Week: 50.1
30-Day IV: 52.7 +3.4
IV Rank: 0.62 (Moderate)
Fundamental
Div. Yield: 0.0%
Earnings: 5-May (Est.)
P/E Ratio:
Market Cap: 467.6 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACHN Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 77,261 40,362 33,777 58,745
Short Term Investments 286,558 368,343 391,429 381,102
Investments - - - -
Accounts Receivable 15,256 385 886 917
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 3,460 2,753 3,008 2,277
Net Property Plant and Equipment 3,479 3,145 3,019 2,377
Other Current Assets 0 0 0 0
Current Assets 382,535 411,843 429,100 443,041
Goodwill and Intangibles 0 0 0 0
Long Term Investments 27,657 0 0 3,034
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 413,875 415,193 432,355 448,656
Short Term Debt 0 0 0 0
Other Non-Current Assets 204 205 236 204
Accounts Payable 7,002 5,449 5,811 6,583
Accrued Liabilities and Other Payables 6,618 8,078 6,795 6,653
Long Term Debt 301 55 114 173
Other Liabilities - - - -
Current Portion of Long Term Debt 351 234 230 227
Total Liabilities 14,421 13,982 13,100 13,788
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income 151 310 311 265
Preferred Stock 0 0 0 0
Current Liabilities 13,971 13,761 12,836 13,463
Common Stock 137 137 137 137
Other Non-Current Liabilities 149 166 150 152
Additional Paid-In Capital 916,584 913,753 911,066 908,232
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -517,418 -512,989 -492,259 -473,766
Total Equity 399,454 401,211 419,255 434,868
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 77,261 81,725 73,664 33,457
Short Term Investments 286,558 377,616 79,215 88,393
Investments - - - -
Accounts Receivable 15,256 506 95 480
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 3,460 2,741 1,901 2,452
Net Property Plant and Equipment 3,479 1,735 1,726 1,265
Other Current Assets 0 0 0 0
Current Assets 382,535 462,588 154,875 124,782
Goodwill and Intangibles 0 0 0 0
Long Term Investments 27,657 0 0 36,139
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 413,875 464,525 156,807 162,417
Short Term Debt 0 0 0 0
Other Non-Current Assets 204 202 206 231
Accounts Payable 7,002 4,133 6,418 4,591
Accrued Liabilities and Other Payables 6,618 10,302 6,446 4,521
Long Term Debt 301 231 279 56
Other Liabilities - - - -
Current Portion of Long Term Debt 351 223 195 291
Total Liabilities 14,421 14,889 13,338 9,459
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income 151 -45 -12 6
Preferred Stock 0 0 0 0
Current Liabilities 13,971 14,658 13,059 9,403
Common Stock 137 137 104 97
Other Non-Current Liabilities 149 0 0 0
Additional Paid-In Capital 916,584 905,256 599,796 534,529
Treasury Stock 0 0 0 0
Other Equity 0 0 -5,737 0
Retained Earnings -517,418 -455,712 -450,682 -381,674
Total Equity 399,454 449,636 143,469 152,958